In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Alpelisib combined with Fluvastatin in the treatment of postmenopausal women and···【more】
Release date:2026-01-05Recommended:201
Balversa is suitable for treating adult patients with locally advanced or metast···【more】
Release date:2026-01-05Recommended:248
Stiripentol is suitable for treating epileptic seizures associated with Dravet s···【more】
Release date:2026-01-05Recommended:245
Used for the treatment of Clostridium difficile-associated diarrhea (CDAD) in ad···【more】
Release date:2026-01-05Recommended:232
Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia.【more】
Release date:2026-01-05Recommended:183
Lenvatinib is indicated for differentiated thyroid carcinoma (DTC), renal cell c···【more】
Release date:2026-01-05Recommended:60
Tucatinib can be used to treat breast cancer and colorectal cancer in adult pati···【more】
Release date:2026-01-05Recommended:175
Vigabatrin is an adjuvant therapy for refractory complex partial epilepsy patien···【more】
Release date:2026-01-05Recommended:148
Entrectinib is a Broad-spectrum antitumor agents.【more】
Release date:2026-01-05Recommended:71
Upadacitinib can regulate abnormal immune responses, alleviate inflammation and ···【more】
Release date:2026-01-05Recommended:116
Recurrent or refractory advanced renal cell carcinoma (RCC) after two or more pr···【more】
Release date:2026-01-05Recommended:160
Adult patients with locally advanced or metastatic ROS1 positive non-small cell ···【more】
Release date:2026-01-05Recommended:195